ViraxClear Supplies The Big Issue Charity with PPE Kits For Their Workers
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, July 14, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that its portfolio company, ViraxClear, is the PPE supplier for The Big Issue Charity (“The Big Issue”) supplying Employee Protection Equipment (“EPE Kits”) to The Big Issue through its ViraxCare platform, www.viraxcare.com.Lord John Baird, founder of The Big Issue, said: “First-off, we want to thank everyone who has supported us and our vendors along the journey we have been through, the generosity of the wonderful British public (and) our corporate partners … We have undertaken a huge health and safety review and put in place a range of measures designed to ensure vendors are able to sell safely from July 6. We want to ensure the public feel 100 per cent safe when choosing to buy from our vendors and have followed the government COVID-19 health & safety guidelines”The Big Issue stated in their Press Release:“We are providing vendors with PPE through generous contributions from partners and the public to our COVID-19 Appeal and donations from ViraxCare PPE supplier. All our vendors will be given safety equipment including face masks, visors, latex gloves and use anti-bacterial gel.”Link to press release:https://www.bigissue.com/latest/the-big-issue-reveals-more-support-for-vendors-in-their-return-to-the-streets/Picture 1: https://www.globenewswire.com/NewsRoom/AttachmentNg/a1433d34-0551-4034-87f7-cc8cbe2de335ViraxCare PPE Distribution
Following donations by ViraxCare, The Big Issue have decided to continue purchasing ViraxCare products for its’ vendors and employees. They have currently purchased 86,000 masks and 14,000 gloves with at least 140,000 more over the next 12 weeks of each to follow. The Big Issue is the first of many large organisations ViraxCare is working with on an ongoing basis.Picture 2: https://www.globenewswire.com/NewsRoom/AttachmentNg/82ab5e28-690e-402d-a336-6654b9455358The Big Issue
The Big Issue is one of the UK’s leading social businesses and exists to offer homeless people, or individuals at risk of homelessness, the opportunity to earn a legitimate income, thereby helping them to reintegrate into mainstream society. It is the world’s most widely circulated street newspaper, published in four continents. From an award-winning magazine offering employment opportunities to people in poverty, a multi-million-pound social investment business supporting enterprise to drive social change, to a charity foundation supporting vendors to rebuild their own pathways to a better future and a shop curating social enterprise products. For 29 years The Big Issue Group has strived to dismantle poverty through creating opportunity, in the process becoming one of the most recognised and trusted brands in the UK.Website:www.bigissue.comViraxCare PPEDr Tomasz George, Chief Scientific Officer of ViraxClear states, “Governments, companies and employees worldwide are keen to resume trading, get back to work, and get the economy moving again, but there is a real concern for workers safety and this must be ensured before any increases in operations. Social distancing and training on infection control are important, as is having effective protective equipment and cleaning products.”“A scientifically-curated kit of key protective equipment will be crucial in allowing employees back to work by creating conditions for an acceptable level of safety in the workplace. It is vital that employers can provide enough safety equipment for their staff to curb, and limit as far as possible, the transmission of COVID-19. ViraxCare ‘Back to Work’ Kits achieve this.”Picture 3: https://www.globenewswire.com/NewsRoom/AttachmentNg/d35b598c-0156-4040-a6bf-2ab8269857ecPicture 4: https://www.globenewswire.com/NewsRoom/AttachmentNg/6b29805b-8283-4f77-bd64-496fb9602924Infrared Thermometer – The thermometers do not require contact with a person and can swiftly measure temperature from 1cm-5cm from the forehead. These are particularly useful for use in public places like a hotel, airport, factory or office. These are battery-operated, handy and easy to use thermometers, which do not require any trained technicians. Whilst they are by no means definitively accurate in the detection of COVID-19, they are widely being used across the world to detect potential symptomatic COVID-19 carriers.Picture 5: https://www.globenewswire.com/NewsRoom/AttachmentNg/db29cca8-395b-468e-8861-87dcbf04857dPulse Oximeter – These easy-to-use devices simply clip on to your finger and measure pulse rate and blood oxygen saturations, which can be key indicators in viral infection.Picture 6: https://www.globenewswire.com/NewsRoom/AttachmentNg/a98db745-057f-4df6-a9b9-9f6e03d0e53eKN95 Masks – ViraxClear has developed its’ own range of KN95, FDA Registered and CE marked masks, which may be comfortably worn for hours.Picture 7: https://www.globenewswire.com/NewsRoom/AttachmentNg/5c738938-5497-421a-b615-39f9c86e37aeDisposable 3 Ply Masks – ViraxClear has developed its’ own range of FDA Registered and CE marked 3-ply disposable masks, which are particularly helpful travelling to and from work.Picture 8: https://www.globenewswire.com/NewsRoom/AttachmentNg/ffd3f5e0-5b30-41bf-b376-b0db0bc088d2Gloves – To reduce the risk of transmitting potential pathogens, particularly during travel to and from the workplace.Picture 9: https://www.globenewswire.com/NewsRoom/AttachmentNg/2647c1ad-b571-49ad-b227-5ab588a9e224Antimicrobial Hand Wipes – these wipes include active agents to kill certain types of potential pathogensPicture 10: https://www.globenewswire.com/NewsRoom/AttachmentNg/a1d8c03e-858a-478a-b20e-ff241e3d4298Website:www.viraxcare.comAbout ViraxClearViraxClear focuses on commercializing novel products that address significant healthcare needs with a specific target on the novel coronavirus (COVID-19). The company’s main focus is marketing its ViraxClear Rapid IgM-IgG Combined Antibody Test. The ViraxClear Rapid IgM-IgG Combined Antibody Test for COVID-19 is a lateral flow immunoassay used to qualitatively detect both early and late marker IgG/IgM antibodies.http://www.viraxclear.com[email protected]About Global CareGlobal Care Capital is a global investment company which specializes in providing early stage financing to private and public companies. The Company engages in new, early stage investment opportunities in previously underdeveloped assets and obtaining positions in early stage investment opportunities that adequately reflect the risk profile.GLOBAL CARE CAPITAL CORP.: Company Contact: Alex Somjen, President & CEO416-319-5744[email protected]Neither the CSE nor its regulation services provider accepts responsibility for the adequacy or accuracy of this release.Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.